Immune Modulatory Vaccines Reprogram the Tumor Microenvironment
Could immunomodulatory vaccines reshape the future of cancer treatment? Professor Mads Hald Andersen, Director of the National Center for Cancer Immune Therapy at Copenhagen University Hospital Herlev and Professor at the University of Copenhagen, presents a new approach targeting the tumor microenvironment — with the potential to enhance the effect of existing immunotherapies.
Relateret indhold
Brænder du for at skrive?
Vil du gerne dele din forskning eller dine kliniske erfaringer med dine kollegaer inden for netop dit speciale? Har du en ide til en artikel, som du gerne vil udgive hos os? Send redaktionen en mail på redaktion@bpno.dk
Send mail til redaktionen